BK
Bhavna Kumar Shah
About Bhavna Kumar Shah
Data last updated:
Bhavna Kumar Shah is a Director at Zil Pharma Enterprises Private Limited (since 2022) and Designated Partner at Claret Life Sciences Llp (since 2019). The companies operate in Pharma and Life Sciences. The largest current company by reported revenue is Zil Pharma Enterprises Private Limited at ₹60.12 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 May 2022 | 2022 | ₹60.12 Cr (FY 2025) | Active | |
| Designated Partner | 21 May 2019 | 2019 | Active |
Board colleagues of Bhavna Kumar Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kumar Suresh Shah | 08457788 | Zil Pharma Enterprises Private Limited , Claret Life Sciences Llp | Director |
| Suresh Laherchand Shah | 09617702 | Zil Pharma Enterprises Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhavna Kumar Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhavna Kumar Shah
Bhavna Kumar Shah currently holds 2 directorships: Zil Pharma Enterprises Private Limited (Director, since 24 May 2022, revenue ₹60.12 Cr (FY 2025)); Claret Life Sciences Llp (Designated Partner, since 21 May 2019).
Bhavna Kumar Shah was first appointed on 21 May 2019 as Designated Partner at Claret Life Sciences Llp. The most recent appointment on record is 24 May 2022 at Zil Pharma Enterprises Private Limited.
The current boards of Bhavna Kumar Shah's companies include Kumar Suresh Shah (Zil Pharma Enterprises Private Limited), Suresh Laherchand Shah (Zil Pharma Enterprises Private Limited).